Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$7,290 | -$668 | -$316 |
| Dep. & Amort. | $1,117 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $97 | $0 | $0 |
| Change in WC | $0 | $2,412 | -$365 |
| Other Non-Cash | $285 | -$2,837 | -$16 |
| Operating Cash Flow | -$5,790 | -$1,092 | -$697 |
| Investing Activities | – | – | – |
| PP&E Inv. | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$178,500 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $180,839 | $0 |
| Investing Cash Flow | $0 | $180,839 | -$178,500 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $180,296 |
| Stock Repurch. | $0 | -$139,354 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $572 | -$138,704 | $180,296 |
| Financing Cash Flow | $572 | -$138,704 | $180,296 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,218 | $41,043 | $1,099 |
| Supplemental Information | – | – | – |
| Beg. Cash | $6,820 | $1,099 | $0 |
| End Cash | $1,601 | $42,142 | $1,099 |
| Free Cash Flow | -$5,790 | -$1,092 | -$697 |